OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

about

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Item

http://www.wikidata.org/entity/Q40060881

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

OMERACT Endorsement of Patient ...... ntibody-associated Vasculitis.

@en

type

Item

label

OMERACT Endorsement of Patient ...... ntibody-associated Vasculitis.

@en

prefLabel

OMERACT Endorsement of Patient ...... ntibody-associated Vasculitis.

@en

P1476

OMERACT Endorsement of Patient ...... ntibody-associated Vasculitis.

@en

P2093

Annelies Boonen

http://www.w3.org/2001/XMLSchema#string

Antoine G Sreih

http://www.w3.org/2001/XMLSchema#string

Beverley Shea

http://www.w3.org/2001/XMLSchema#string

Carol A McAlear

http://www.w3.org/2001/XMLSchema#string

David Cuthbertson

http://www.w3.org/2001/XMLSchema#string

Don Gebhart

http://www.w3.org/2001/XMLSchema#string

Ebony Easley

http://www.w3.org/2001/XMLSchema#string

George C Casey

http://www.w3.org/2001/XMLSchema#string

Georgia Lanier

http://www.w3.org/2001/XMLSchema#string

Gunnar Tomasson

http://www.w3.org/2001/XMLSchema#string

P2860

Exploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT Process

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective

A comparative review of generic quality-of-life instruments.

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.

Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).

Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis

P304

1529-1535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3899/JRHEUM.161139

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alfred D Mahr

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28864650

http://www.w3.org/2001/XMLSchema#string

P932

5951181

http://www.w3.org/2001/XMLSchema#string